Licensing & Co-Development Opportunities
 
 
Becoming A Partner
 
Developing alliances is one of GalMed's strategies for success.
 

Galmed seeks strategic collaboration with biotechnology and pharmaceutical companies to enhance the growth and market opportunity beneficial to both companies. Galmed continues to build its pipeline and advance existing drugs, fulfilling its commitment in bringing breakthrough therapeutics in the field of liver and cholesterol metabolism to patients.

The company is interested to discuss licensing and co-development opportunities related to Aramchol or development of new or improved drugs based on Fabac technology.



For more information, please contact:

Itzchak Angel, Ph.D.
Vice President, Business Development
itzchak@galmedgroup.com


 

 
 

Back to Top